3 recruiting, 2 unknown. 5 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 5 | Recruiting 3, Unknown 2 |
Follow Disorders of Sex Development: new trials by email Literature Review of Disorders of Sex Development trials Research Report on Disorders of Sex Development
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study Saxenda - Panhypopituitarism, Craniopharyngioma | Early Phase 1 | Unknown | Seoul National University Hospital | 50 | 2022-11-28 | 2024-01-23 |
| Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism? Spironolactone, Placebo - Hyperandrogenism, Polycystic Ovary Syndrome | Early Phase 1 | Recruiting | University of Virginia | 32 | 2021-11-12 | 2025-08-05 |
| Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess? Spironolactone - Polycystic Ovary Syndrome, Puberty Disorders | Early Phase 1 | Unknown | University of Virginia | 24 | 2019-12-18 | 2023-10-27 |
| Hyperandrogenemia and Altered Day-night LH Pulse Patterns Micronized progesterone, Spironolactone, Placebo - Hyperandrogenism, Polycystic Ovary Syndrome | Early Phase 1 | Recruiting | University of Virginia | 32 | 2016-07-21 | 2025-08-05 |
| Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism Micronized progesterone suspension, Placebo - Puberty, Hyperandrogenism | Early Phase 1 | Recruiting | University of Virginia | 36 | 2008-06-01 | 2025-08-05 |
Hyperandrogenism (4) · Polycystic Ovary Syndrome (4) · Combined Pituitary Hormone Deficiency (1) · Craniopharyngioma (1) · Sexual Infantilism (1)
Congenital Abnormalities (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Endocrine System Diseases (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Gonadal Disorders (5) · Male Urogenital Diseases (5) · Neoplasms (5) · Urogenital Abnormalities (5) · Urogenital Diseases (5) · 46, XX Disorders of Sex Development (4) · Adnexal Diseases (4) · Adrenogenital Syndrome (4) · Cysts (4)
Spironolactone (3) · Progesterone (2) · Liraglutide (1)
University of Virginia (4) · Seoul National University Hospital (1)
United States (4) · South Korea (1)
Christine Burt Solorzano, MD (2) · Christine Burt Solorzano, M.D. (1) · Christine M Burt Solorzano, MD (1)
P50HD028934 (1), R01HD102060 (1)